Shin Nippon Biomedical

FDA declines to approve Shin Nippon Biomedical's migraine drug
Reuters
Thu, 01/18/24 - 11:05 am
FDA
Shin Nippon Biomedical
migraines
With skin in the game, Satsuma's partner offers buyout to get migraine spray to market
Fierce Biotech
Mon, 04/17/23 - 12:07 pm
Satsuma Pharmaceuticals
Japan
migraines
Shin Nippon Biomedical
M&A